Maximilian J. Mair

1.3k total citations
45 papers, 539 citations indexed

About

Maximilian J. Mair is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maximilian J. Mair has authored 45 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Genetics and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maximilian J. Mair's work include Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Maximilian J. Mair is often cited by papers focused on Glioma Diagnosis and Treatment (19 papers), Brain Metastases and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Maximilian J. Mair collaborates with scholars based in Austria, Germany and Italy. Maximilian J. Mair's co-authors include Anna S. Berghoff, Matthias Preusser, Martin J. van den Bent, Marjolein Geurts, Georg Widhalm, Priscilla K. Brastianos, Michael Weller, Karin Dieckmann, Émilie Le Rhun and Barbara Kiesel and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

In The Last Decade

Maximilian J. Mair

35 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maximilian J. Mair Austria 14 211 201 123 95 79 45 539
Ningying Wu United States 13 175 0.8× 102 0.5× 122 1.0× 57 0.6× 115 1.5× 35 626
Signe Spetalen Norway 16 112 0.5× 131 0.7× 173 1.4× 46 0.5× 77 1.0× 43 607
Alissa A. Thomas United States 11 139 0.7× 168 0.8× 66 0.5× 29 0.3× 97 1.2× 35 514
Jean-François Minéo France 7 71 0.3× 93 0.5× 83 0.7× 208 2.2× 43 0.5× 8 482
B. Storer United States 15 246 1.2× 73 0.4× 104 0.8× 26 0.3× 193 2.4× 20 815
Annette Wundes United States 15 265 1.3× 51 0.3× 44 0.4× 33 0.3× 97 1.2× 35 813
Michele M. Bloomer United States 12 130 0.6× 52 0.3× 33 0.3× 92 1.0× 108 1.4× 41 597
Lauro José Gregianin Brazil 18 209 1.0× 36 0.2× 264 2.1× 39 0.4× 170 2.2× 66 665
Margarita Romeo Spain 12 525 2.5× 45 0.2× 157 1.3× 48 0.5× 160 2.0× 63 1.0k
Beverly Bell United States 12 169 0.8× 121 0.6× 175 1.4× 29 0.3× 207 2.6× 26 721

Countries citing papers authored by Maximilian J. Mair

Since Specialization
Citations

This map shows the geographic impact of Maximilian J. Mair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maximilian J. Mair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maximilian J. Mair more than expected).

Fields of papers citing papers by Maximilian J. Mair

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maximilian J. Mair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maximilian J. Mair. The network helps show where Maximilian J. Mair may publish in the future.

Co-authorship network of co-authors of Maximilian J. Mair

This figure shows the co-authorship network connecting the top 25 collaborators of Maximilian J. Mair. A scholar is included among the top collaborators of Maximilian J. Mair based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maximilian J. Mair. Maximilian J. Mair is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çifçi, Didem, Erwin Tomasich, Maximilian J. Mair, et al.. (2025). Density and entropy of immune cells within the tumor microenvironment of primary tumors and matched brain metastases. Acta Neuropathologica Communications. 13(1). 34–34. 1 indexed citations
2.
Berger, J.M., M. Korpan, Maximilian J. Mair, et al.. (2025). 2804MO Cancer-associated cachexia indicators in patients with solid cancer. Annals of Oncology. 36. S1391–S1392.
3.
Mair, Maximilian J., Sabrina Hartenbach, Erwin Tomasich, et al.. (2025). Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma. European Journal of Nuclear Medicine and Molecular Imaging. 52(8). 2771–2781. 1 indexed citations
4.
5.
Berghoff, Anna S., Matthias Preusser, Maximilian J. Mair, et al.. (2025). Personalized targeted glioblastoma therapies by ex vivo drug screening: Advanced brain tumor therapy clinical trial (ATTRACT).. Journal of Clinical Oncology. 43(16_suppl). 1 indexed citations
6.
7.
Albert, Nathalie L., Émilie Le Rhun, Giuseppe Minniti, et al.. (2024). Translating the theranostic concept to neuro-oncology: disrupting barriers. The Lancet Oncology. 25(9). e441–e451. 13 indexed citations
8.
Mair, Maximilian J., Rainer Puhr, Marlene Troch, et al.. (2023). Prophylactic treatment with oral azithromycin in cancer patients during the COVID-19 pandemic (OnCoVID): a randomized, single-blinded, placebo-controlled phase 2 trial. Infectious Agents and Cancer. 18(1). 9–9. 1 indexed citations
9.
Mair, Maximilian J., Angelika M. Starzer, Julia Fürst, et al.. (2023). 2115P Pre-cachexia incidence in patients with solid cancer: A cross-sectional study. Annals of Oncology. 34. S1107–S1107. 3 indexed citations
10.
Mair, Maximilian J., Rupert Bartsch, Émilie Le Rhun, et al.. (2023). Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours. Nature Reviews Clinical Oncology. 20(6). 372–389. 45 indexed citations
11.
Mair, Maximilian J., Gerwin Heller, Rainer Puhr, et al.. (2022). Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clinical Cancer Research. 28(20). 4565–4573. 8 indexed citations
12.
Mair, Maximilian J., Elizabeth A. Connolly, Maria Kfoury, et al.. (2022). Career and Professional Development for Young Oncologists. Oncology Research and Treatment. 46(3). 67–71. 2 indexed citations
13.
Mair, Maximilian J., Michele Ceccarelli, Andrea Anichini, et al.. (2022). Immunotherapy for brain metastases and primary brain tumors. European Journal of Cancer. 179. 113–120. 13 indexed citations
14.
Roth, Patrick, Sebastian Winklhofer, Antonia Müller, et al.. (2021). Neurological complications of cancer immunotherapy. Cancer Treatment Reviews. 97. 102189–102189. 55 indexed citations
15.
Mair, Maximilian J. & Anna S. Berghoff. (2021). ASCO 2021: Highlights in central nervous system tumors. memo - Magazine of European Medical Oncology. 14(4). 323–327.
16.
Mair, Maximilian J., Aysegül Ilhan‐Mutlu, Ariane Steindl, et al.. (2020). Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours. ESMO Open. 5(6). e000863–e000863. 16 indexed citations
17.
Mair, Maximilian J., et al.. (2020). Clinical outcomes and prognostic factors in patients with multiple myeloma in South Tyrol: a retrospective single-center analysis. Annals of Hematology. 99(5). 1031–1040. 1 indexed citations
18.
Mair, Maximilian J., Barbara Kiesel, Georg Widhalm, et al.. (2020). Lymphocyte-activation gene 3 (LAG-3) expression in the inflammatory microenvironment of glioma.. Journal of Clinical Oncology. 38(15_suppl). 2553–2553. 6 indexed citations
19.
Englinger, Bernhard, Maximilian J. Mair, Walter Miklos, et al.. (2017). Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance. British Journal of Cancer. 116(4). 489–500. 13 indexed citations
20.
Fartaćek, Reinhold, et al.. (1995). Multicenter double blind study of paroxetine and amitriptyline in elderly depressed inpatients. Psychopharmacology. 119(3). 277–281. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ningying Wu Breakdown of academic impact, for papers by Signe Spetalen Breakdown of academic impact, for papers by Alissa A. Thomas Breakdown of academic impact, for papers by Jean-François Minéo Breakdown of academic impact, for papers by B. Storer Breakdown of academic impact, for papers by Annette Wundes Breakdown of academic impact, for papers by Michele M. Bloomer Breakdown of academic impact, for papers by Lauro José Gregianin Breakdown of academic impact, for papers by Margarita Romeo Breakdown of academic impact, for papers by Beverly Bell
Rankless by CCL
2026